Anti-EpCAM cancer vaccine (Aphton)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-EpCAM cancer vaccine (Aphton)
Drug Alias Name่‚ฟ็˜ค็–ซ่‹— - Aphton็™Œ็—‡็–ซ่‹— - AphtonIGN-101
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionEpithelial cell adhesion molecule modulatorsImmunostimulants
TargetsEpithelial cell adhesion molecule
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAphton Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAltropusAphton Corp
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A